Holocene Advisors’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-193,483
Closed -$2.28M 861
2023
Q2
$2.28M Buy
193,483
+24,974
+15% +$284K 0.01% 520
2023
Q1
$1.94M Buy
168,509
+155,761
+1,222% +$1.93M 0.01% 469
2022
Q4
$158K Buy
+12,748
New +$163K ﹤0.01% 670
2022
Q3
Sell
-136,799
Closed -$1.91M 936
2022
Q2
$1.91M Buy
136,799
+2,209
+2% +$29.5K 0.01% 562
2022
Q1
$2M Hold
134,590
0.01% 521
2021
Q4
$1.82M Buy
134,590
+89,435
+198% +$1.27M 0.01% 573
2021
Q3
$665K Buy
+45,155
New +$763K ﹤0.01% 729

Other funds holding SBRA

Holocene Advisors's SBRA Position: Q3 2023 in Review

Holocene Advisors sold out of Sabra Healthcare REIT (SBRA) in Q3 2023, closing a stake of 193,483 shares — an estimated $2.28M sold.

Holocene Advisors first reported a position in SBRA in Q3 2021 and held it in 7 quarters. The position peaked at $2.28M in Q2 2023. 329 funds tracked by Wall St. Rank hold SBRA as of Q3 2023.

  • Holocene Advisors reported no remaining Sabra Healthcare REIT position as of Q3 2023 after selling out during the quarter.
  • Holocene Advisors sold 193,483 Sabra Healthcare REIT shares in Q3 2023, an estimated $2.28M.
  • Holocene Advisors first reported a position in Sabra Healthcare REIT in Q3 2021 and held it in 7 quarters.
  • Holocene Advisors's Sabra Healthcare REIT position peaked at $2.28M in Q2 2023.
  • 329 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2023.

Based on Holocene Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.